Expression of the TGF-β coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis

Oncogene

Volumn 22, Issue 38, 2003, Pages 5976-5985

  Quintanilla, Miguel ^a   Ramirez, Jose Ramón ^b   Pérez Gómez, Eduardo ^a   Romero, Diana ^a   Velasco, Beatriz ^c   Letarte, Michelle ^d,e   López Novoa, Jose Miguel ^f   Bernabéu, Carmelo ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Endoglin; Keratinocyte; TGF ; Tumor progression

Indexed keywords

CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; EPIDERMIS CELL; HETEROZYGOTE; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; TRANSGENIC MOUSE; UNDIFFERENTIATED CARCINOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIGENS, CD; CARCINOMA; CELLS, CULTURED; EPIDERMIS; HUMANS; KERATINOCYTES; MICE; MICE, MUTANT STRAINS; NEOPLASMS, EXPERIMENTAL; PAPILLOMA; RECEPTORS, CELL SURFACE; REFERENCE VALUES; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA; MUS MUSCULUS;

EID: 0141594914     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206841     Document Type: Article

References (70)

1. Akhurst RJ and Balmain A. (1999). J. Pathol., 187, 82-90.
2. Akhurst RJ, Fee F and Balmain A. (1988). Nature, 331, 363-365.
3. Alexandrov MG and Moses HL. (1995). Cancer Res., 55, 1452-1457.
4. Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI, Nicotra MR, Cattelan A, Natali PG and Maio M. (1996). Br. J. Cancer, 74, 1586-1591.
5. Arthur HM, Ure J, Smith AJH, Renforth G, Wilson DJ, Torsney E, Charlton R, Parums DV, Joweet T, Marchuk DA, Burn J and Diamond AG. (2000). Dev. Biol., 217, 42-53.
6. Barbara NP, Wrana JL and Letarte M. (1999). J. Biol. Chem., 274, 584-594.
7. Bellón T, Corbí A, Lastres P, Calés C, Cebrián M, Vera S, Cheifetz S, Massagué J, Letarte M and Bernabeu C. (1993). Eur. J. Immunol., 23, 2340-2345.
8. Bodey B, Bodey Jr B, Siegel SE and Kaiser HE. (1998). Anticancer Res., 18, 2701-2710.
9. Bolontrade MF, Stern MC, Binder RL, Zenklusen JC, Gimenez-Conti IB and Conti CJ. (1998). Carcinogenesis, 19, 2107-2113.
10. Bourdeau A, Dumont DJ and Letarte M. (1999). J. Clin. Invest., 104, 1343-1351.
11. Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR and Letarte M. (2001). Am. J. Pathol., 158, 2011-2020.
12. Buchmann A, Ruggeri B, Klein-Szanto AJP and Balmain A. (1991). Cancer Res., 51, 4097-4101.
13. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES and Thorpe PE. (1995). Clin. Cancer Res., 1, 1623-1634.
14. Caulín C, Scholl FG, Frontelo P, Gamallo C and Quintanilla M. (1995). Cell Growth Differ., 6, 1027-1035.
15. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J and Letarte M. (1992). J. Biol. Chem., 267, 19027-19030.
16. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A and Akhurst RJ. (1996). Cell, 86, 531-542.
17. Derynck R, Akhurst RJ and Balmain A. (2001). Nat. Genet., 29, 117-129.
18. Diaz-Guerra M, Haddow S, Bauluz C, Jorcano JL, Cano A, Balmain A and Quintanilla M. (1992). Cancer Res., 52, 680-687.
19. Diez-Marques L, Ortega-Velazquez R, Langa C, Rodriguez-Barbero A, Lopez-Novoa J M, Lamas S and Bernabeu C. (2002). Biochim. Biophys. Acta, 21, 1587:36-44.
20. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, Natali PG and Maio M. (2001). J. Cell Physiol., 188, 1-7.
21. Fowlis DJ, Flanders KC, Duffie E, Balmain A and Akhurst RJ. (1992). Cell Growth Differ., 3, 81-91.
22. Frontelo P, González-Garrigues M, Vilaró S, Gamallo C, Fabra A and Quintanilla M. (1998). Exp. Cell Res., 244, 420-432.
23. Ge AZ and Butcher EC. (1994). Gene, 138, 201-206.
24. Gougos A and Letarte M. (1988). J. Immunol., 141, 1925-1933.
25. Gougos A and Letarte M. (1990). J. Biol. Chem., 265, 8361-8364.
26. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A and Bernabeu C. (2002). J. Biol. Chem., 277, 29197-29209.
27. Guttmacher AE, Marchuck DA and White RIJ. (1995). N. Eng. J. Med., 333, 918-924.
28. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
29. Haruta Y and Seon BK. (1986). Proc. Natl. Acad. Sci. USA, 83, 7898-7902.
30. Jindal SK, Ishii E, Letarte M, Vera S, Teerds KJ and Dorrington JH. (1995). Biol. Reprod., 52, 1027-1037.
31. Klein-Szanto AJP, Larcher F, Bonfil RD and Conti CJ. (1989). Carcinogenesis, 10, 2169-2172.
32. Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM and Bundred N. (1999). Cancer Res., 59, 856-861.
33. Larcher F, Murillas R, Bolontrade M, Conti CJ and Jorcano JL. (1998). Oncogene, 17, 303-311.
34. Lastres P, Bellón T, Cabanas C, Saánchez-Madrid F, Acevedo A, Gougos A, Letarte M and Bernabeu C. (1992). Eur. J. Immunol., 22, 393-397.
35. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, López LA, Langa C, Fabra A, Letarte M and Bernabeu C. (1996). J. Cell Biol., 133, 1109-1121.
36. Letterio JJ and Roberts AB. (1998). Annu. Rev. Immunol., 16, 137-161.
37. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L and Bernabeu C. (1998a). J. Biol. Chem., 273, 33011-33019.
38. Letamendia A, Lastres P, Almendro N, Raab U, Buhring H-J, Kumar S and Bernabeu C. (1998b). Int. J. Cancer, 76, 541-546.
39. Li C, Guo B, Bernabeu C and Kumar S. (2001). Microsc. Res. Technol., 52, 437-449.
40. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C and Kumar S. (2000). FASEB J., 14, 55-64.
41. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB and Wendel DP. (1999). Science, 284, 1534-1537.
42. Liu Y, Jovanovic B, Pins M, Lee C and Bergan RC. (2002). Oncogene, 21, 8272-8281.
43. Marchuk DA and Lux A. (2001). The Metabolic and Molecular Bases of Inherited Disease IV 8th Edition. Scriver CR, Beaudet AL, Sly WS, Andle D (eds). Medical Publishing Division: McGraw-Hill, pp. 5419-5431.
44. Massagué J. (1998). Annu. Rev. Biochem., 67, 753-791.
45. Massagué J, Blain SW and Lo RS. (2000). Cell, 103, 295-309.
46. Navarro P, Gómez M, Pizarro A, Gamallo C, Quintanilla M and Cano A. (1991). J. Cell Biol., 115, 517-533.
47. Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann E. (1996). Genes Dev., 10, 2462-2477.
48. Oft M, Akhurst RJ and Balmain A. (2002). Nat. Cell Biol., 4, 487-494.
49. Oft M, Heider K-H and Beug H. (1998). Curr. Biol., 8, 1243-1252.
50. Patamalai B, Burrow DL, Gimenez-Conti I, Zenklusen JC, Conti CJ, Klein-Szanto AJP and Fischer SM. (1994). Mol. Carcinog., 9, 220-229.
51. Piek E and Roberts AB. (2001). Adv. Cancer Res., 83, 1-54.
52. Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ and Balmain A. (1998). Cell Growth Differ., 9, 393-404.
53. Qu R, Silver MM and Letarte M. (1998). Cell Tissue Res., 292, 333-343.
54. Quackenbush EJ and Letarte M. (1985). J. Immunol., 134, 1276-1285.
55. Quintanilla M, Brown K, Ramsden M and Balmain A. (1986). Nature, 322, 78-80.
56. Reiners JJ, Nesnow S and Slaga TJ. (1984). Carcinogenesis, 5, 301-307.
57. Rich J, Borton A and Wang X. (2001). Microsc. Res. Technol., 52, 363-373.
58. Roberts AB and Sporn MB. (1990). Peptide Growth factors and their Receptors - Handbook of Experimental Pharmacology. Sporn MB, Roberts AB (eds). Spinger-Verlag: Heidelberg, pp. 419-472.
59. Robledo MM, Hidalgo A, Lastres P, Arroyo AG, Bernabeu C, Sánchez-Madrid F and Teixido J. (1996). Br. J. Haematol., 93, 507-514.
60. Rodriguez-Peña A, Eleno N, Duwell A, Arevalo M, Perez-Barriocanal F, Flores O, Docherty N, Bernabeu C, Letarte M and López-Novoa JM. (2002). Hypertension, 40, 713-720.
61. Shovlin CL and Letarte M. (1999). Thorax, 54, 714-729.
62. Skobe M, Rockwell P, Goldstein N, Vosseler S and Fusenig NE. (1997). Nat. Med., 3, 1222-1227.
63. St-Jacques S, Cymerman U, Pece N and Letarte M. (1994). Endocrinology, 134, 2645-2657.
64. Takahashi N, Haba A, Matsuno F and Seon BK. (2001). Cancer Res., 61, 7846-7854.
65. Taylor G, Lehrer M, Jensen PJ, Sun T-T and Lavker RM. (2000). Cell, 102, 451-461.
66. Velasco B, Ramirez JR, Relloso M, Li C, Kumar S, Lopez-Bore JP, Pérez-Barriocanal F, López-Novoa JM, Cowan PJ, d'Apice AJF and Bernabeu C. (2001). Gene Therapy, 8, 897-904.
67. Vincent EB, Runyan RB and Weeks DL. (1998). Dev. Dyn., 213, 237-247.
68. Yuspa SH. (1994). Cancer Res., 54, 1178-1189.
69. Yuspa SH, Morgan D, Lichti U, Spangler EF, Michel D, Kilkenny A and Hennings H. (1986). Carcinogenesis, 7, 949-958.
70. Zhang H, Shaw AR, Mak A and Letarte M. (1996). J. Immunol., 156, 564-573.